本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lantern Pharma Inc.

4.08
+0.380010.27%
盤後4.130.0485+1.19%19:05 EDT
成交量:12.40萬
成交額:48.72萬
市值:4,406.16萬
市盈率:-2.28
高:4.20
開:3.88
低:3.77
收:3.70
52周最高:6.12
52周最低:2.55
股本:1,079.94萬
流通股本:820.24萬
量比:1.01
換手率:1.51%
股息:- -
股息率:- -
每股收益(TTM):-1.7857
每股收益(LYR):-1.9309
淨資產收益率:-88.59%
總資產收益率:-48.35%
市淨率:3.52
市盈率(LYR):-2.11

資料載入中...

2024/08/09

重要事件披露

Form 8-K - Current report
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/07

SEC問詢函

Form CORRESP - Correspondence
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/29

重要事件披露

Form 8-K - Current report